Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

During the Trading Day
36.34 -0.87 / -2.34%
As of 4:05pm ET
Day’s Change
During After-Hours   Switch to standard view »
36.40 +0.06 / +0.17%
Volume: 99.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 1
Quarter 2
Quarter 3
Quarter 4
Operating ActivitiesNet Income / Starting Line2.3B784.0M580.0M--
Total Other Cash Flow-2.7B-149.0M27.0M--
Funds From Operations-10.0M987.0M990.0M--
Funds From/For Other Operating Expenses-12.0M46.0M-205.0M--
Net Cash Flow - Operating Activities2.0M941.0M1.2B--
InvestingIncrease In Investments-213.0M-1.8B-570.0M--
Capital Expenditures-235.0M-216.0M-411.0M--
Fixed Asset Disposal230.0M2.3B0.00--
Net Assets From Acquisitions -----231.0M--
Other Investing - Sources13.0M15.0M15.0M--
Net Cash Flow Investing-205.0M242.0M-1.2B--
FinancingShort Term Borrowings-1.5B-47.0M-501.0M--
Long Term Borrowings2.5B0.000.00--
Long Term Debt Reduction-10.0M-23.0M-3.0M--
Net Proceeds Stock Sale156.0M57.0M50.0M--
Common Preferred Redeemed-1.3B-1.0M-2.0M--
Common Dividends----------
Cash Dividends Paid - Total-364.0M-360.0M-359.0M--
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing-550.0M-374.0M-815.0M--
Exchange RateEffect of Exchange Rate on Cash-84.0M13.0M-99.0M--
Net Change In Cash-753.0M809.0M-817.0M0.00